Valora Therapeutics logo

Valora Therapeutics

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$30M


Valora Therapeutics Inc. is a biotechnology company developing novel immunotherapeutics using its proprietary AbLec platform to modulate glyco-immune checkpoints.

Total Funding

$30M

Headquarters

San Diego, USA

Founded

N/A

Focus Areas

Biotechnology
Immunotherapeutics
Glyco-immune
Antibody-Lectin
Platform
R&D

Investors